| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |